Citations (41)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
B. Strandvik, M. Brönnegåd, H. Gilljam & J. Carlstedt-Duke. (1988) Relation between Defective Regulation of Arachidonic Acid Release and Symptoms in Cystic Fibrosis. Scandinavian Journal of Gastroenterology 23:sup143, pages 1-4.
Read now
Read now
Articles from other publishers (40)
Clarisse Vandebrouck & Thierry Ferreira. (2020) Glued in lipids: Lipointoxication in cystic fibrosis. EBioMedicine 61, pages 103038.
Crossref
Crossref
Dušan Garić, Daciana Catalina Dumut, Juhi Shah, Juan Bautista De Sanctis & Danuta Radzioch. (2020) The role of essential fatty acids in cystic fibrosis and normalizing effect of fenretinide. Cellular and Molecular Life Sciences 77:21, pages 4255-4267.
Crossref
Crossref
Craig E. Wheelock & Birgitta Strandvik. (2020) Abnormal n-6 fatty acid metabolism in cystic fibrosis contributes to pulmonary symptoms. Prostaglandins, Leukotrienes and Essential Fatty Acids 160, pages 102156.
Crossref
Crossref
Dušan Garić, Juan B. De Sanctis, Daciana Catalina Dumut, Juhi Shah, Maria Johanna Peña, Mina Youssef, Basil J. Petrof, Francisek Kopriva, John W. Hanrahan, Marian Hajduch & Danuta Radzioch. (2020) Fenretinide favorably affects mucins (MUC5AC/MUC5B) and fatty acid imbalance in a manner mimicking CFTR-induced correction. Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids 1865:2, pages 158538.
Crossref
Crossref
Elias Seidl, Hannah Kiermeier, Gerhard Liebisch, Manfred Ballmann, Sebastian Hesse, Karl Paul-Buck, Felix Ratjen, Ernst Rietschel & Matthias Griese. (2019) Lavage lipidomics signatures in children with cystic fibrosis and protracted bacterial bronchitis. Journal of Cystic Fibrosis 18:6, pages 790-795.
Crossref
Crossref
Antonio Recchiuti, Domenico Mattoscio & Elisa Isopi. (2019) Roles, Actions, and Therapeutic Potential of Specialized Pro-resolving Lipid Mediators for the Treatment of Inflammation in Cystic Fibrosis. Frontiers in Pharmacology 10.
Crossref
Crossref
Giovana R. Punaro, Deyse Y. Lima, Adelson M. Rodrigues, Samuel Pugliero, Margaret G. Mouro, Marcelo M. Rogero & Elisa M.S. Higa. (2019) Cupuaçu extract reduces nitrosative stress and modulates inflammatory mediators in the kidneys of experimental diabetes. Clinical Nutrition 38:1, pages 364-371.
Crossref
Crossref
Réginald Philippe & Valerie Urbach. (2018) Specialized Pro-Resolving Lipid Mediators in Cystic Fibrosis. International Journal of Molecular Sciences 19:10, pages 2865.
Crossref
Crossref
Xiaoling Zang, José J. Pérez, Christina M. Jones, María Eugenia Monge, Nael A. McCarty, Arlene A. Stecenko & Facundo M. Fernández. (2017) Comparison of Ambient and Atmospheric Pressure Ion Sources for Cystic Fibrosis Exhaled Breath Condensate Ion Mobility-Mass Spectrometry Metabolomics. Journal of the American Society for Mass Spectrometry 28:8, pages 1489-1496.
Crossref
Crossref
Adam Seegmiller & Michael O’Connor. 2015. Diet and Exercise in Cystic Fibrosis. Diet and Exercise in Cystic Fibrosis
353
364
.
Adam Seegmiller. (2014) Abnormal Unsaturated Fatty Acid Metabolism in Cystic Fibrosis: Biochemical Mechanisms and Clinical Implications. International Journal of Molecular Sciences 15:9, pages 16083-16099.
Crossref
Crossref
Gabriella Wojewodka, Juan B. De Sanctis, Joanie Bernier, Julie Bérubé, Heather G. Ahlgren, Jim Gruber, Jennifer Landry, Larry C. Lands, Dao Nguyen, Simon Rousseau, Andrea Benedetti, Elias Matouk & Danuta Radzioch. (2014) Candidate Markers Associated with the Probability of Future Pulmonary Exacerbations in Cystic Fibrosis Patients. PLoS ONE 9:2, pages e88567.
Crossref
Crossref
Peter Witters, Lieven Dupont, François Vermeulen, Marijke Proesmans, David Cassiman, Pierre Wallemacq & Kris De Boeck. (2013) Lung transplantation in cystic fibrosis normalizes essential fatty acid profiles. Journal of Cystic Fibrosis 12:3, pages 222-228.
Crossref
Crossref
Hélène Tiesset, Henry Bernard, Nana Bartke, Christopher Beermann, Elisabeth Flachaire, Jean-Luc Desseyn, Frédèric Gottrand & Marie-Odile Husson. (2011) (n-3) Long-Chain PUFA Differentially Affect Resistance toPseudomonas aeruginosaInfection of Male and FemalecftrMice. The Journal of Nutrition 141:6, pages 1101-1107.
Crossref
Crossref
Munir M. Zaman, Camilia R. MartinCharlotte Andersson, Abdul Q. Bhutta, Joanne E. Cluette-Brown, Michael Laposata & Steven D. Freedman. (2010)
Linoleic acid supplementation results in increased arachidonic acid and eicosanoid production in CF airway cells and in
cftr
−/−
transgenic mice
. American Journal of Physiology-Lung Cellular and Molecular Physiology 299:5, pages L599-L606.
Crossref
Crossref
Neeraj Vij. (2010) Linoleic acid supplement in cystic fibrosis: friend or foe?. American Journal of Physiology-Lung Cellular and Molecular Physiology 299:5, pages L597-L598.
Crossref
Crossref
Birgitta Strandvik. (2010) Fatty acid metabolism in cystic fibrosis. Prostaglandins, Leukotrienes and Essential Fatty Acids 83:3, pages 121-129.
Crossref
Crossref
Christina Keen, Anna-Carin Olin, Susanne Eriksson, Anna Ekman, Anders Lindblad, Samar Basu, Christopher Beermann & Birgitta Strandvik. (2010) Supplementation With Fatty Acids Influences the Airway Nitric Oxide and Inflammatory Markers in Patients With Cystic Fibrosis. Journal of Pediatric Gastroenterology & Nutrition 50:5, pages 537-544.
Crossref
Crossref
Charlotte Andersson, M. Rabie Al-Turkmani, Juanito E. Savaille, Ragheed Alturkmani, Waddah Katrangi, Joanne E. Cluette-Brown, Munir M. Zaman, Michael Laposata & Steven D. Freedman. (2008) Cell culture models demonstrate that CFTR dysfunction leads to defective fatty acid composition and metabolism. Journal of Lipid Research 49:8, pages 1692-1700.
Crossref
Crossref
M. Rabie Al-Turkmani, Steven D. Freedman & Michael Laposata. (2007) Fatty acid alterations and n-3 fatty acid supplementation in cystic fibrosis. Prostaglandins, Leukotrienes and Essential Fatty Acids 77:5-6, pages 309-318.
Crossref
Crossref
Christina Keen, Anna-Carin Olin, Asa Edentoft, Eva Gronowitz & Birgitta Strandvik. (2007) Airway Nitric Oxide in Patients With Cystic Fibrosis Is Associated With Pancreatic Function, Pseudomonas Infection, and Polyunsaturated Fatty Acids. Chest 131:6, pages 1857-1864.
Crossref
Crossref
Beth A. McCormick & Randall J. Mrsny. 2009. Bacterial-Epithelial Cell Cross-Talk. Bacterial-Epithelial Cell Cross-Talk
269
298
.
Alice Panchaud, Yann Kernen & Michel Roulet. (2006) Place des apports oraux en acides gras oméga-3 dans la mucoviscidose. Nutrition Clinique et Métabolisme 20:1, pages 41-47.
Crossref
Crossref
N Peretti, V Marcil, E Drouin & E Levy. (2005) Mechanisms of lipid malabsorption in Cystic Fibrosis: the impact of essential fatty acids deficiency. Nutrition & Metabolism 2:1.
Crossref
Crossref
Anniek Werner, Marloes E.J. Bongers, Marcel J. Bijvelds, Hugo R. de Jonge & Henkjan J. Verkade. (2004) No indications for altered essential fatty acid metabolism in two murine models for cystic fibrosis. Journal of Lipid Research 45:12, pages 2277-2286.
Crossref
Crossref
Gerald J. Mizejewski & Kenneth A. Pass. (2001) Fatty Acids, Alpha-Fetoprotein, and Cystic Fibrosis. Pediatrics 108:6, pages 1370-1373.
Crossref
Crossref
J. Sarles. (2001) Physiopathologie des lésions pancréatiques dans la mucoviscidose. Archives de Pédiatrie 8, pages 409-411.
Crossref
Crossref
E. M. App, R. Bals, J. Behr, G. Döring, M. Griese, H. Lindemann, A. Schuster & C. Vogelmeier. 2001. Cystische Fibrose. Cystische Fibrose
121
184
.
Steven D. Freedman, Julie C. Shea, Paola G. Blanco & Juan G. Alvarez. (2000) Fatty acids in cystic fibrosis. Current Opinion in Pulmonary Medicine 6:6, pages 530-532.
Crossref
Crossref
Julie C. Shea, Isabel K. Hopper, Paola G. Blanco & Steven D. Freedman. (2000) Advances in nutritional management of chronic pancreatitis. Current Gastroenterology Reports 2:4, pages 323-326.
Crossref
Crossref
Steven D. Freedman, Paola Blanco, Julie C. Shea & Juan G. Alvarez. (2000) MECHANISMS TO EXPLAIN PANCREATIC DYSFUNCTION IN CYSTIC FIBROSIS. Medical Clinics of North America 84:3, pages 657-664.
Crossref
Crossref
Steven D. Freedman, Mark H. Katz, Eliza M. Parker, Michael Laposata, Mark Y. Urman & Juan G. Alvarez. (1999)
A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in
cftr
−/−
mice
. Proceedings of the National Academy of Sciences 96:24, pages 13995-14000.
Crossref
Crossref
Anthony D. Postle, Ann Mander, Kenneth B. M. Reid, Jiu-Yao Wang, Sarah M. Wright, Maria Moustaki & John O. Warner. (1999) Deficient Hydrophilic Lung Surfactant Proteins A and D with Normal Surfactant Phospholipid Molecular Species in Cystic Fibrosis. American Journal of Respiratory Cell and Molecular Biology 20:1, pages 90-98.
Crossref
Crossref
LUCIO MIELE, ELEONORA CORDELLA-MIELE, MINGZHAO XING, RAYMOND FRIZZELL & ANIL B. MUKHERJEE. (1997)
Cystic Fibrosis Gene Mutation (ΔF
508
) Is Associated with an Intrinsic Abnormality in Ca
2+
-Induced Arachidonic Acid Release by Epithelial Cells
. DNA and Cell Biology 16:6, pages 749-759.
Crossref
Crossref
B. Strandvik, E. Svensson & H.W. Seyberth. (1996) Prostanoid biosynthesis in patients with cystic fibrosis. Prostaglandins, Leukotrienes and Essential Fatty Acids 55:6, pages 419-425.
Crossref
Crossref
G Lepage, J Champagne, N Ronco, A Lamarre, I Osberg, RJ Sokol & CC Roy. (1996) Supplementation with carotenoids corrects increased lipid peroxidation in children with cystic fibrosis. The American Journal of Clinical Nutrition 64:1, pages 87-93.
Crossref
Crossref
AP Sampson, DA Spencer, CP Green, PJ Piper & JF Price. (2012) Leukotrienes in the sputum and urine of cystic fibrosis children.. British Journal of Clinical Pharmacology 30:6, pages 861-869.
Crossref
Crossref
B. STRANDVIK. (1989) Relation between Essential Fatty Acid Metabolism and Gastrointestinal Symptoms in Cystic Fibrosis. Acta Paediatrica 78, pages 58-65.
Crossref
Crossref
David Henke, Roberta M. Danilowicz, John F. Curtis, Richard C. Boucher & Thomas E. Eling. (1988) Metabolism of arachidonic acid by human nasal and bronchial epithelial cells. Archives of Biochemistry and Biophysics 267:2, pages 426-436.
Crossref
Crossref
Hans Gilljam, Olof Andersson, Åke Ellin, Bengt Robertson & Birgitta Strandvik. (1988) Composition and surface properties of the bronchial lipids in adult patients with cystic fibrosis. Clinica Chimica Acta 176:1, pages 29-37.
Crossref
Crossref